Anti-Inflammatory Actions of the Heme Oxygenase-1 Pathway
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2541-2551
Author(s):
M. J. Alcaraz, P. Fernandez and M. I. Guillen
Stem Cell Gene Therapy for Chronic Renal Failure
Journal:
Current Gene Therapy
Volume:
3
Page:
387-394
Author(s):
T. Yokoo, K. Sakurai, T. Ohashi and T. Kawamura
Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Journal:
Current Gene Therapy
Volume:
3
Page:
418-451
Author(s):
E. Kizana and I. E. Alexander
Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2113-2130
Author(s):
Yoshisuke Nishi
Dual COX Inhibition and Upper Gastrointestinal Damage
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2191-2195
Author(s):
M. M. Skelly and C. J. Hawkey
ATP-Sensitive K+ Channel Openers: Old Drugs with New Clinical Benefits for the Heart
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
251-258
Author(s):
Tetsuji Miura and Takayuki Miki
Therapeutic Value of Statins for Vascular Remodeling
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
273-279
Author(s):
Hirotaka Nagashima and Hiroshi Kasanuki
Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
281-299
Author(s):
Uwe Gottmann, Fokko J. van der Woude and Claude Braun
Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
301-313
Author(s):
Victoria E. Mendizabal and Edda Adler-Graschinsky
Cardiovascular Diseases and the Nitric Oxide Pathway
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
335-346
Author(s):
Silvia Llorens and Eduardo Nava